References
- Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020. 395(10225):709-733.
- United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. 2020. https://adr.usrds.org/2020
- Ravani P, Palmer SC, Oliver MJ, et al. Associations between Hemodialysis Access Type and Clinical Outcomes. J Am Soc Nephrol. 2013. 24(3):465-473. DOI: 10.1681/ASN.2012070643
- Nguyen DB, Shugart A, Lines C, et al. National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014. Clinical J Am Soc Nephrol. 2017. 12(7):1139-1146. DOI: 10.2215/CJN.11411116
- Gasch O, Almendral A, Andrés M, et al. Surveillance of catheter-related bacteremia in VINCat program. Enfermedades infecciosas y microbiologia clinica (English ed). 2025. 43:S19-S27. DOI: 10.1016/j.eimce.2024.12.010
- Urrea Ayala M, Almendral A, Jordan García I, et al. Central line-associated bloodstream infections (CLABSI) in pediatric and neonatal intensive care units-The VINCat program 2013-2022. Enfermedades infecciosas y microbiologia clinica (English ed). 2025. 43:S90-S97. DOI: 10.1016/j.eimce.2024.09.014
- Allon M, Brouwer-Maier DJ, Abreo K, et al. Recommended Clinical Trial End Points for Dialysis Catheters. Clinical J Am Soc Nephrol. 2018. 13(3):495-500. DOI: 10.2215/CJN.12011116
- Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006. 21(4):1024-1031. DOI: 10.1093/ndt/gfi104
- Sahli F, Feidjel R, Laalaoui R. Hemodialysis catheter-related infection: rates, risk factors and pathogens. J Infect Public Health. 2017. 10(4):403-408. DOI: 10.1016/j.jiph.2016.06.008
- Malhotra R, Marcelli D, von Gersdorff G, et al. Relationship of Neutrophil-to-Lymphocyte Ratio and Serum Albumin Levels with C-Reactive Protein in Hemodialysis Patients: Results from 2 International Cohort Studies. Nephron. 2015. 130(4):263-270. DOI: 10.1159/000437005
- Liao J, Wei D, Sun C, Yang Y, Wei Y, Liu X. Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-tolymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis. BMC Nephrol. 2022. 23(1):393. DOI: 10.1186/s12882-022-03020-1
- KAYA B, PAYDAŞ S, KARA E. Relationship between mortality and baseline platelet to lymphocyte ratio in hemodialysis patients. Cukurova Med J. 2019. 44:400-411. DOI: 10.17826/cumj.566275
- Liao CK, Yu YL, Lin YC, et al. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis. World J Surg Oncol. 2021. 19(1):139. DOI: 10.1186/s12957-021-02253-y
- Yang J, Huang J, Yu B, et al. Long-term predialysis blood pressure variability and outcomes in hemodialysis patients. J Clin Hypertens (Greenwich). 2022. 24(2):148-155. DOI: 10.1111/jch.14398
- Li LL, Yang YQ, Qiu M, Wang L, Yuan HL, Zou RC. The clinical significance of neutrophil-lymphocyte ratio in patients treated with hemodialysis complicated with lung infection. Medicine (Baltimore). 2021. 100(29):e26591. DOI: 10.1097/MD.0000000000026591
- Kim HK, Jun H, Ko SY. Neutrophil-to-lymphocyte ratio as a predictor for early mortality in older patients requiring hemodialysis. insights for hemodialysis access planning. BMC Nephrol. 2025. 26(1):2. DOI: 10.1186/s12882-024-03924-0
- Catabay C, Obi Y, Streja E, et al. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients. Am J Nephrol. 2017. 46(5):408-416. DOI: 10.1159/000484177
- Mayne KJ, Lees JS, Rutherford E, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort. Clin Kidney J. 2023. 16(3):512-520. DOI: 10.1093/ckj/sfac248
- Zhang J, Lu X, Wang S, Li H. High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis. Biomed Res Int. 2021. 2021(1). DOI: 10.1155/2021/9958081
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013. 17(3):391-396. DOI: 10.1111/hdi.12040
- Chávez Valencia V, Orizaga de la Cruz C, Mejía Rodríguez O, et al. Inflammation in hemodialysis and their correlation with neutrophillymphocyte ratio and platelet- lymphocyte ratio. Nefrologia. 2017. 37(5):554-556. DOI: 10.1016/j.nefroe.2016.12.014
- Yaprak M, Turan MN, Dayanan R, et al. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol. 2016. 48(8):1343-1348. DOI: 10.1007/s11255-016-1301-4
- Zhang Y, Zhang A, Wei L, et al. A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients. Ren Fail. 2023. 45(2). DOI: 10.1080/0886022X.2023.2258228
- Kim S, Molnar MZ, Fonarow GC, et al. Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol. 2016. 220:862-870. DOI: 10.1016/j.ijcard.2016.06.074
- Jiang W, Chen Y, Yan C, Ma Y, Chen Q, Zhan X. Mean platelet volume may predict all-cause and cardiovascular mortality among incident peritoneal dialysis patients. Ren Fail. 2023. 45(2). DOI: 10.1080/0886022X.2023.2261541
- Bilen Y, Cankaya E, Keles M, et al. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients? Ren Fail. 2014. 36(1):69-72. DOI: 10.3109/0886022X.2013.832310
- Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophilto-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med. 2020;38(3):641-647. DOI: 10.1016/j.ajem.2019.10.023
- Wu H, Cao T, Ji T, et al. Predictive value of the neutrophil-tolymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis. Front Immunol. 2024;15:1336456 DOI: 10.3389/fimmu.2024.1336456
- Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. DOI: 10.1158/1078-0432.CCR-14-0442
- Zhu Q, Dai L. Prognostic implications of systemic immune-inflammation index and systemic inflammation response index in hemodialysis patients. BMC Nephrol. 2025;26(1):322. DOI: 10.1186/s12882-025-04223-y
- Liang L, Su Q. Systemic immune-inflammation index and the short-term mortality of patients with sepsis: A meta-analysis. Biomol Biomed. 2025;25(4):798-809. DOI: 10.17305/bb.2024.11494